REVB
Price
$1.92
Change
-$0.08 (-4.00%)
Updated
Sep 12 closing price
Capitalization
3.26M
TSHA
Price
$3.07
Change
-$0.17 (-5.25%)
Updated
Sep 12 closing price
Capitalization
837.48M
59 days until earnings call
Interact to see
Advertisement

REVB vs TSHA

Header iconREVB vs TSHA Comparison
Open Charts REVB vs TSHABanner chart's image
Revelation Biosciences
Price$1.92
Change-$0.08 (-4.00%)
Volume$262.99K
Capitalization3.26M
Taysha Gene Therapies
Price$3.07
Change-$0.17 (-5.25%)
Volume$4.42M
Capitalization837.48M
REVB vs TSHA Comparison Chart in %
Loading...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REVB vs. TSHA commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REVB is a StrongBuy and TSHA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 15, 2025
Stock price -- (REVB: $1.92 vs. TSHA: $3.07)
Brand notoriety: REVB and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REVB: 56% vs. TSHA: 141%
Market capitalization -- REVB: $3.26M vs. TSHA: $837.48M
REVB [@Biotechnology] is valued at $3.26M. TSHA’s [@Biotechnology] market capitalization is $837.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REVB’s FA Score shows that 1 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • REVB’s FA Score: 1 green, 4 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, TSHA is a better buy in the long-term than REVB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REVB’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • REVB’s TA Score: 4 bullish, 6 bearish.
  • TSHA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than REVB.

Price Growth

REVB (@Biotechnology) experienced а -33.10% price change this week, while TSHA (@Biotechnology) price change was -8.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

TSHA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($837M) has a higher market cap than REVB($3.26M). TSHA has higher P/E ratio than REVB: TSHA (2.70) vs REVB (0.00). TSHA YTD gains are higher at: 77.457 vs. REVB (-91.323). REVB has higher annual earnings (EBITDA): -8.08M vs. TSHA (-91.48M). TSHA has more cash in the bank: 313M vs. REVB (5.17M). REVB has less debt than TSHA: REVB (0) vs TSHA (59.6M). TSHA has higher revenues than REVB: TSHA (8.1M) vs REVB (0).
REVBTSHAREVB / TSHA
Capitalization3.26M837M0%
EBITDA-8.08M-91.48M9%
Gain YTD-91.32377.457-118%
P/E Ratio0.002.700%
Revenue08.1M-
Total Cash5.17M313M2%
Total Debt059.6M-
TECHNICAL ANALYSIS
Technical Analysis
REVBTSHA
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
71%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRAX0.600.02
+2.76%
Virax Biolabs Group Limited
CMPO19.440.22
+1.14%
CompoSecure
RDZN0.990.01
+0.92%
Roadzen
FBIZ51.79-0.75
-1.43%
First Business Financial Services
WMS141.49-5.29
-3.60%
Advanced Drainage Systems

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-4.00%
GNPX - REVB
48%
Loosely correlated
+12.84%
TCRT - REVB
46%
Loosely correlated
-2.94%
OGEN - REVB
34%
Loosely correlated
+5.22%
TOVX - REVB
31%
Poorly correlated
-1.26%
TSHA - REVB
31%
Poorly correlated
-5.25%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with PCVX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-5.25%
PCVX - TSHA
45%
Loosely correlated
-2.69%
XNCR - TSHA
40%
Loosely correlated
+1.18%
ERAS - TSHA
40%
Loosely correlated
-3.11%
RGNX - TSHA
38%
Loosely correlated
-3.06%
HLVX - TSHA
37%
Loosely correlated
N/A
More